• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection

    Volume
    62
    Pagination
    1246 - 1255
    DOI
    10.1016/j.jhep.2014.12.024
    Journal
    JOURNAL OF HEPATOLOGY
    Issue
    6
    ISSN
    0168-8278
    Metadata
    Show full item record
    Authors
    Ferenci, P; Asselah, T; Foster, GR; Zeuzem, S; Sarrazin, C; Moreno, C; Ouzan, D; Maevskaya, M; Calinas, F; Morano, LE
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7119
    Collections
    • Centre for Immunobiology [921]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.